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Incretins such as glucagon-like peptide 1 (GLP-1) are released from the gut and potentiate insulin
release in a glucose-dependent manner. Although this action is generally believed to hinge on
cAMP and protein kinase A signaling, up-regulated beta cell intermediary metabolism may also
play a role in incretin-stimulated insulin secretion. By employing recombinant probes to image
ATP dynamically in situ within intact mouse and human islets, we sought to clarify the role of
GLP-1-modulated energetics in beta cell function. Using these techniques, we show that GLP-1
engages a metabolically coupled subnetwork of beta cells to increase cytosolic ATP levels, an
action independent of prevailing energy status. We further demonstrate that the effects of GLP-1
are accompanied by alterations in the mitochondrial inner membrane potential and, at elevated
glucose concentration, depend upon GLP-1 receptor-directed calcium influx through voltage-
dependent calcium channels. Lastly, and highlighting critical species differences, beta cells within
mouse but not human islets respond coordinately to incretin stimulation. Together, these findings
suggest that GLP-1 alters beta cell intermediary metabolism to influence ATP dynamics in a
species-specific manner, and this may contribute to divergent regulation of the incretin-axis in
rodents and man. (Molecular Endocrinology 28: 860–871, 2014)
Type 2 diabetes is a socioeconomically costly diseasestate usually characterized by pancreatic beta cell de-
compensation in the face of increased resistance to circu-
lating insulin (1). The resulting glucose intolerance leads
to undesirable sequelae including neuropathy, renal fail-
ure, cardiac disease, and increased cancer risk. Under nor-
mal conditions, the secretion of insulin is primarily driven
by the aerobic glycolysis of glucose, raising cytosolic ATP/
ADP ratios [ATP/ADP]cyto. This leads to the closure of
hyperpolarizing ATP-sensitive K channels (KATP) and
calcium (Ca2)-dependent exocytosis due to Ca2 influx
through voltage-dependent Ca2 channels (VDCC). Se-
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cretion is further augmented by “amplifying” pathways
(2, 3), which may involve intracellular signaling cascades
such as those mediated by cAMP, acting upstream of ex-
change protein activated by cAMP (Epac) (4) and protein
kinase A (5), as well as AMP-activated protein kinase (6),
protein kinase C (7) and MAPK (8, 9).
In addition to glucose, a number of alternative fuels
and circulating factors regulate insulin secretion. Nota-
bly, gut-derived incretins including glucagon-like peptide
1 (GLP-1) and glucose-dependent insulinotropic polypep-
tide are liberated from entero-endocrine cells in response
to bile acid and nutrient flux (10, 11), and act to poten-
tiate insulin release in a glucose-dependent manner (12,
13). Due to the latter and other properties, incretin-based
analogs are becoming mainstays of type 2 diabetes treat-
ment. Although the effects of GLP-1 upon adenylate cy-
clase (AC) activity, [cAMP]i oscillations, Epac signaling
and exocytosis are increasingly well characterized (4, 14),
whether incretins are able to alter beta cell intermediary
metabolism to influence insulin secretion remains contro-
versial. Thus, whereas dynamic luciferase-based studies
by us have demonstrated increased free cytosolic [ATP] in
GLP-1-stimulated MIN6 immortalized beta cells (15),
others have failed to detect any effect of the GLP-1 mi-
metic, exendin-4, onmitochondrial ATP levels in primary
rodent islets (16). Nonetheless, the latter studies did re-
port a significant increase in glucose utilization in re-
sponse to GLP-1 at elevated glucose concentration, al-
though glucose oxidation was not changed by the incretin
at the time points studied.
Further suggesting that incretin-stimulated insulin se-
cretion may in part involve altered metabolism are the
observations that: 1) GLP-1 and exendin-4 stimulate
large oscillations in intracellular Ca2 concentrations
([Ca2]i), both in rodent and human beta cells (16–18); 2)
ATP-consuming processes are required for cytoplasmic
Ca2 removal and intracellular store refilling (19); 3) mi-
tochondrial Ca2 uptake activates citrate cycle dehydro-
genases, augmenting ATP production (20); 4) excessive
mitochondrial Ca2 uptake may depolarize the inner
mitochondrial membrane, resulting in a temporary cessa-
tion of ATP synthesis (21); and 5) Ca2 stimulates energy-
consuming processes such as exocytosis (22). Corre-
spondingly, we (19) and others (21) have recently
demonstrated that glucose-dependent oscillations in in-
tracellular ATP are strongly influenced by Ca2 in pan-
creatic beta cells.
To further investigate a role for incretin in beta cell
energetics, we used a recombinant strategy to direct ex-
pression of the GFP-based ATP-binding protein Perceval
(23) throughout the first few layers of mouse and human
primary islets (21). Although previously deployed in dis-
sociated beta cells (24–26) and small numbers of cells in
intact islets (21), this technique has not been employed to
investigate ATP/ADP dynamics across a large population,
nor have responses to incretins been examined in islets.
Using this approach, we show that GLP-1 modulates
ATP dynamics, resulting in [ATP/ADP]cyto rises. These
effects were independent of prevailing cell metabolic sta-
tus because GLP-1 was still able to induce ATP oscilla-
tions in the presence of low (3 mM) glucose concentra-
tion, which is nonpermissive for insulin secretion.
Moreover, GLP-1-stimulated ATP dynamics at elevated
glucose concentration were reliant upon engagement of
the GLP-1-receptor (GLP-1R) and ensuing Ca2 influx
because they could be blocked reversibly using exendin
9-39 and verapamil, respectively. Lastly, species differ-
ences in GLP-1-regulated “metabolic connectivity” were
present, with mouse but not human islets responding to
stimulus with synchronous ATP dynamics. Thus, GLP-1
affects beta cell intermediary metabolism through altera-
tions to ATP dynamics in a species-specific manner, and
this may play an important role in incretin-modulated
beta cell function at both low and elevated glucose
concentrations.
Results
Adenovirus-harboring Perceval is tropic for beta
cells and reports ATP changes in intact islets
Specific immunohistochemical analyses detected Per-
ceval expression predominantly in the insulin immunopo-
sitive cell population, confirming the reported (27–29)
tropism of adenoviruses for beta (Figure 1A) over alpha
(Figure 1B) and other endocrine cells within mouse islets
of Langerhans. Nipkow spinning disk microscopy (30)
was therefore used to capture the effects of glucose and
other secretagogues on cytoplasmic ATP/ADP dynamics
throughout the population of beta cells residing within
the first few layers of intact islets. Elevation of glucose
from 3–17 mM induced a multiphasic response typified
by an initial increase in [ATP/ADP]cyto (F/Fmin), followed
by the development of superimposed oscillations, as pre-
viously reported (Figure 1, C and D) (ATP/ADP 
0.13  0.02 AU, n  14 recordings from six animals)
(21). Just under half of the imaged population (44%)
responded to glucose with increases in apparent [ATP]cyto
(Figure 1E), suggesting that a subpopulation of beta cells
may act to integrate metabolic information before prop-
agating this throughout the syncytium as Ca2waves (31,
32).
To determine whether cAMP could interfere with the
Perceval ATP-binding site, HEK293 cells expressing the
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ATP sensor were lysed before dialysis and exposure to
cAMP at varying concentrations of ATP. Consistent with
our previous studies (25, 26), Perceval displayed a 10–
30% increase in fluorescence intensity following ATP
binding in the absence of ADP, and this was similar fol-
lowing incubation with increasing concentrations of
cAMP (0.1–1 M), (logEC50 1.83, 1.75, 1.70, and 2.1
at 0, 0.01, 0.1, and 1McAMP, respectively) (Figure 1F).
GLP-1 induces oscillations in cytosolic ATP/ADP
In the presence of high (17mM) glucose concentration,
the addition of 20 nM GLP-1 to Perceval-expressing
mouse islets stimulated increases in fluorescence, which
were superseded by the appearance of low-frequency os-
cillations (Figure 2A). This dose of incretin has previously
been shown to maximally stimulate intracellular Ca2
rises in islets (17). Importantly, in our hands, GLP-1
evoked a barely detectable decrease in intracellular pH
(0.05 pH unit) (23, 26), indicating that the fluctuations
in Perceval fluorescence intensity are likely to result from
oscillations in [ATP/ADP]cyto, as opposed to acidifica-
tion/alkalinization. Following incubation at nonpermis-
sive (3 mM) glucose concentration, GLP-1 was similarly
able to induce oscillatory increases in Perceval fluores-
cence (Figure 2B), although the incretin was unable to
alter Ca2 responses under these conditions (81.1  6.0
vs 8.9  2.3% GLP-1-responsive cells, G3  GLP-1 vs
G11  GLP-1, respectively; n  6 recordings from three
animals, P  .01). As observed for the effects of glucose
(Figure 1E), the action of GLP-1 involved the recruitment
of a subnetwork of beta cells. Thus, 40% of the re-
corded population responded toGLP-1 in the aboveman-
ner (Figure 2, C—E). Intriguingly, sharp drops in appar-
ent [ATP/ADP]cyto were seen between peaks (Figure 2, A
and B). These deflections seemed to be part of normal
stochastic behavior because they were not influenced by
prevailing glucose concentration (Figure 2F) and per-
sisted in the presence of cyclosporin A (CysA), an inhib-
itor of the mitochondrial permeability transition pore
(Figure 2G) (33). Although GLP-1 tended to stimulate
smaller [ATP/ADP]cyto rises than 17mMglucose, this was
not significant (ATP/ADP 0.13 0.02 vs 0.08 0.01
AU, 17 mM glucose vs GLP-1 applied at 3 mM glucose,
respectively; n 13–14 recordings from six animals, non-
significant, NS) (Figure 2H). Notably, the incretin was
still able to augment [ATP]cyto even in the continued pres-
ence of high (17 mM) glucose (Figure 2H). Similar results
were obtained using conventional luciferase-based detec-
tion of ATP (Table 1).
GLP-1 drives increases in inner mitochondrial
membrane potential, which are dependent
on glucose
At elevated glucose concentration, both enhanced sup-
ply of glycolytically derived pyruvate andCa2 activation
of key dehydrogenases (20) accelerate citrate cycle flux in
beta cell mitochondria, elevating the inner mitochondrial
membrane potential (m) (26). The consequent activa-
tion of the F1/F0 ATP-synthase then results in accelerated
ATP production, potentially raising [ATP/ADP]cyto and
countering decreases in the latter driven by cytosolic ATP-
consuming reactions. Conversely, excessive Ca2 uptake,
and hence an accumulation of positive charge, may exert
a direct depolarizing effect to lower m.
Figure 1. The ATP/ADP-sensor Perceval reports beta cell metabolism
in intact islets. A, Specific immunohistochemistry for insulin
demonstrates the preferential expression of Perceval in beta cells
(DAPI, blue; scale bar shown). B, As for A, but immunostaining against
glucagon showing absence of the probe in alpha cells. C, Elevated
glucose concentration increases Perceval fluorescence reflecting
increases in cytoplasmic ATP/ADP ratio ([ATP/ADP]cyto). D,
Representative recording of a Perceval-expressing islet before and
during exposure to high glucose (G17; 17 mM glucose) (n  14
recordings from six animals) (red, raw; gray, smoothed) (scale bar, 50
m). E, Glucose engages a subpopulation (44%) of metabolically-
active beta cells, which respond with [ATP/ADP]cyto increases. F, Dose-
response graph depicting ATP-induced increases in dialyzed Perceval
fluorescence, which are unaffected by the presence of increasing
cAMP concentrations (0–1 M) (sigmoidal dose-response fitted to 2–3
independent repeats).
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To determine whether GLP-1-induced increases in
[ATP/ADP]cyto may be due at least in part to increases in
m,we dynamically tracked fluorescence of the potential-
sensitive fluorescent probe tetram-
ethyl rhodamine ethylester (TMRE)
in beta cells within whole islets. In
response to elevated (17 mM) glu-
cose, cells demonstrated rapid and
large increases in TMRE intensity,
indicative of mitochondrial hyper-
polarization (Figure 3A), as ex-
pected (19, 34, 35). By comparison,
GLP-1 at both low (3 mM) and high
(17 mM) glucose concentrations
induced slower and smaller in-
creases in TMRE fluorescence (Fig-
ure 3, B and C). This observation is
concordant with the smaller [ATP/
ADP]cyto increase elicited by GLP-1
vs glucose. However, the smaller in-
crease in m elicited by GLP-1 at
17 mM compared with 3 mM glu-
cose (0.1 AU) is discordant with
the larger increment change in [ATP/
ADP]cyto induced by the incretin at
the same glucose concentration.
Hence, GLP-1 causes a larger in-
crease in [ATP/ADP]cyto for a given
m increase at high (17 mM) glu-
cose concentration (Figure 3D).
Cytosolic ATP/ADP increases
require GLP-1 receptor
activation
We next sought to determine
whether GLP1-R occupancy was a
prerequisite for the modulation of
ATP dynamics by GLP-1. Confirm-
ing a role for the GLP-1R in beta cell
metabolism was the finding that ex-
endin 9-39 (Ex 9-39), a specific
GLP-1R antagonist (36), reversibly
prevented GLP-1 from affecting
ATP dynamics (0.08  0.02 vs
0.14  0.02 events/minutes, during
and after Ex 9-39, respectively; n 8
recordings,P .05) (Figure3,EandF).
To assess whether the effects of
GLP-1 on [ATP/ADP]cyto were likely
to involve the generation of intracel-
lular cAMP, islets were exposed to
forskolin (FSK), a cAMP-raising
agent (5). As for GLP-1, FSK elicited
a step-change in [ATP/ADP]cyto (ATP/ADP  0.09 
0.02, n 13 recordings), although this was notable by the
Figure 2. GLP-1 induces [ATP/ADP]cyto increases in intact islets under low and high glucose
conditions. A, 20 nM GLP-1 increases cytoplasmic ATP in islets perifused with 17 mM glucose
(G17) (top panel; representative trace; red, raw; gray, smoothed). Wavelet analysis shows the
effects of GLP-1 on the period and power (0–1  blue-red) of ATP oscillation frequency. B, As
for A, but islets exposed to 3 mM glucose (G3). C, GLP-1 engages a subpopulation of
metabolically-coupled beta cells at 17 mM glucose. D, As for C but in the presence of 3 mM
glucose. E, Representative images showing Perceval fluorescence in an islet before and after
introduction of GLP-1 (image cropped to display a single islet; scale bar, 115 m). F, Glucose
concentration does not modulate the effects of GLP-1 on ATP oscillation frequency (NS,
nonsignificant; Mann-Whitney U test on the nonbinned data, n  13 recordings from six
animals). G, Cyclosporin A (CysA) does not prevent appearance of downward deflections in [ATP/
ADP]cyto (NS, nonsignificant vs GLP-1  CysA; Student paired t test, n  8 recordings from four
animals). H, Glucose and GLP-1 are equipotent at elevating [ATP/ADP]cyto in islets and the incretin
can elicit additional increases at high (17 mM) glucose concentration (NS, nonsignificant and **,
P  .01 vs G3; one-way ANOVA followed by Bonferonni’s post hoc test, n  13–14 recordings
from six animals).
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absence of oscillations, most likely due to global activa-
tion of soluble ACs (Figure 3, G and H).
Calcium-dependency of GLP-1-evoked ATP
increases
Because GLP-1-induced ATP increases may depend
upon or provoke intracellular Ca2 rises due to effects on
KATP, dual imaging experiments were performed in iso-
lated beta cells. This preparation was used to minimize
photobleaching and interference between signals derived
from the two probes that complicated measurements in
intact islets. Multiparametric recordings using Perceval
and Fura Red revealed that the onset of the ATP/ADP
response to GLP-1 preceded any increases in cytosolic
Ca2 (Figure 4, A and B and Supplemental Figure 1),
indicating that initiation of the latter is likely to be a
downstream consequence rather than the cause of incre-
tin-induced [ATP/ADP]cyto, increases. In this case, tolbu-
tamidewas used as a control to stimulate large Ca2 rises,
which precede net ATP/ADP consumption (Figure 4C).
As for experiments using intact islets, FSK was able to
evoke increases in ATP in dissociated cells and this could
also be mimicked using the phosphodiesterase inhibitor
isobutyl methyl xanthine (IBMX) (Figure 4D).
Mitochondrial Ca2 sequestration stimulates citrate
cycle dehydrogenases (20, 37) to increase ATP produc-
tion. Therefore, the effects of extracellular Ca2 chelation
were examined to delineate whether continued Ca2 in-
flux through VDCCs was required for the actions of
GLP-1 on [ATP/ADP]cyto at elevated glucose concentra-
tion, or whether intracellular pathways were relatively
more important. Islets perifused with buffer containing
zero added Ca2 plus 1 mM ethylene glycol tet-
raacetic acid (EGTA) failed to display any changes in
[ATP/ADP]cyto following application of GLP-1 (Figure 4,
E and F). Because the removal of external Ca2may lead
to depletion of internal Ca2 stores or islet dissociation,
Ca2 influx through L-type VDCC was blocked using 10
M verapamil. In line with the above observations, vera-
pamil inhibited the effects of GLP-1 on ATP dynamics
(0.03  0.01 vs 0.14  0.02 events/minutes, during and
after verapamil, respectively; n  9 recordings, P  .01)
(Figure 4, G and H).
GLP-1 modulates ATP dynamics in a
species-specific manner
We have recently shown that incretins augment insulin
secretion in human islets by boosting beta cell coopera-
tivity in a process termed “incretin-regulated cell connec-
tivity” (17). Given that similar effects are largely absent in
mouse islets, we wondered whether incretin could differ-
entially affect ATP/ADP dynamics to influence themetab-
olism thought to drive ionic oscillations (38, 39). To in-
vestigate this, large-scale mapping of cell-cell correlations
was used to determine the effects of GLP-1 on the popu-
lation organization of metabolic oscillations in mouse
and human tissue over a 30–40-minute period (17, 40).
During GLP-1 application, the responsive subpopulation
within mouse islets mounted synchronous deflections in
[ATP/ADP]cyto (Figure 5A). By contrast, human islets re-
sponded to the same challenge with largely asynchronous
ATP oscillations (Figure 5A). In line with this, correlated
activity wasmuch higher inmouse comparedwith human
islets (Figure 5B), as evidenced by lower levels of meta-
bolic connectivity in the latter species (90.7  4.6 vs
55.6  4.7% significantly correlated cell pairs, mouse vs
human tissue, respectively; n  8 recordings from three
donors and four animals, P  .01) (Figure 5C).
Discussion
The literature surrounding the action of incretin on beta
cell ATP/ADP ratios is contentious, with the existence of
conflicting reports regarding the effects of the incretins
upon cellular metabolism and energetics (15, 16). By
combining recombinant expression of the ATP sensor
Perceval with in situ imaging of ATP/ADP dynamics in
intact mouse islets, we demonstrate that GLP-1 likely in-
fluences beta cell intermediary metabolism at both low
and high glucose concentrations. Mechanistically, these
effects involved changes in mitochondrial potential, GLP-
1R engagement, and ATP-triggered Ca2 influx through
VDCC, and could bemimicked using the cAMP-elevating
compounds FSK or IBMX (see Figure 6 for a schematic).
Our observations with Perceval reflect steady-state
[ATP/ADP]cyto and, as such, report the balance between
Table 1. Luciferase-Based Measures of ATP Concentration in Glucose- and GLP-1-Treated Islets (n  8 animals)
GLP-1 nM
Glucose mM
0 20
3 17 3 17
ATP pmol/islet 232.7  50.2 495.9  105.7a 797.5  230.3b 1002  183.2b
a P  .05 vs 3 mM glucose-alone; Student t test.
b P  .05 vs 3 mM glucose-alone; ANOVA followed by Dunnett’s multiple comparison test.
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the rates of ATP synthesis and degradation. However,
GLP-1 seems unlikely to inhibit ATP-consuming pro-
cesses under the conditions used here because it acutely
acts to enhance ionic fluxes and insulin secretion (17).
Thus, increases in [ATP/ADP]cyto in response to the incre-
tin seem more likely to reflect accelerated ATP synthesis.
However, we cannot formally exclude the possibility that
factors other than enhanced metabolism, such as a redis-
tribution of ATP between different intracellular pools (eg,
secretory granules or the endoplasmic reticulum) (41),
contribute to the observed actions of GLP-1 on the cyto-
solic ATP/ADP ratio.
In response to elevated glucose, and extending our ear-
lier findings, which used the less sensitive photoprotein
Figure 3. GLP-1 decreases mitochondrial potential and engages its
cognate receptor to increase [ATP/ADP]cyto. A, Elevated glucose (17
mM; G17) stimulates rapid and large excursions in TMRE fluorescence,
indicating mitochondrial hyperpolarisation (representative trace from
n  6 recordings from four animals). B, GLP-1 under elevated glucose
concentration slowly and subtly increases TMRE fluorescence,
indicating minor hyperpolarizing effects on mitochondrial potential
(representative trace from n  6 recordings from four animals). C, As
for B but in the presence of 3 mM glucose (representative trace from
n  7 recordings from four animals). D, TMRE responses to GLP-1 are
significantly lower than those to glucose (**, P  .01 vs G17-alone,
one-way ANOVA followed by Bonferonni’s post hoc test). E,
Representative Perceval trace showing reversible blockade of GLP-1
effects by 100 nM exendin 9-39 (Ex 9-39) (gray, raw; red, smoothed).
F, Ex 9-39 abolishes GLP-1-induced [ATP/ADP]cyto dynamics and rises
(*, P  .05 vs GLP-1  Ex 9-39, Student paired t test, n  11
recordings). G, Forced elevations in cAMP using forskolin (FSK) lead to
increases in [ATP/ADP]cyto. H, FSK evoked ATP rises in all experiments
performed (13/13). Unless otherwise stated, experiments are from
islets taken from  three animals.
Figure 4. GLP-1 alters beta cell metabolism to initiate the Ca2 influx
required to support further [ATP/ADP]cyto increases. A, Simultaneous
recordings of Perceval (blue) and Fura-Red (red) in single beta cells
reveal that GLP-1-stimulated ATP rises precede those of Ca2 influx. B,
Summary bar graph showing the advancement of [ATP/ADP]cyto
responses relative to those of Ca2 when cells are stimulated with
GLP-1 (measured period is shown with arrows on A and B) (n  5
recordings). C, As for A, but 200 M tolbutamide (Tolb) to stimulate
large increases in Ca2 and ensuing ATP consuming processes (n  5
recordings). D, Representative traces showing effects of 10 M
forskolin (FSK) and 100 M isobutylmethylxanthine (IBMX) on [ATP/
ADP]cyto in dissociated beta cells (n  5 recordings). E, Extracellular
Ca2 chelation using EGTA suppresses ATP-responses to GLP-1
(representative trace from n  11 recordings; red, smoothed; gray,
raw). F, EGTA blocked GLP-1 actions in all experiments conducted
(9/9). G, As for E, but in the presence of 10 M of the L-type VDCC
blocker verapamil. H, Verapamil (Ver) abolishes GLP-1-induced [ATP/
ADP]cyto dynamics and rises (**, P  .01 vs GLP-1  verapamil,
Student paired t test, n  11 recordings).
doi: 10.1210/me.2014-1038 mend.endojournals.org 865
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 15 May 2015. at 08:56 For personal use only. No other uses without permission. . All rights reserved.
firefly luciferase to image cytosolic and mitochondrial-
free ATP in islets (19), mouse beta cells responded by
mounting oscillations in ATP/ADP that were coordinated
across the imaged population. This may reflect a bidirec-
tional interplay between metabolic and ionic signals that
is phase-set by negative feedback emanating at the level of
Ca2, and which drives the slow oscillations in KATP con-
ductance and Ca2 influx (21, 39). Notably, only50%
of the Perceval-expressing population displayed [ATP/
ADP]cyto rises/oscillations following exposure to high glu-
cose, raising the intriguing possibility that a metabolically
coupled subnetwork of beta cells orchestrates the global
Ca2 dynamics known to underlie insulin secretion in
mouse islets (31, 42). Although electrotonic coupling via
gap junctions would allow nonmetabolically active beta
cells to contribute to islet-wide Ca2 oscillations (31, 43),
previous studies have shown that nicotinamide adenine
dinucleotide phosphate (NAD(P)H) increases are ob-
served in 90% of beta cells within islets (44). Potential
explanations for these discrepancies include the existence
of functional heterogeneity between beta cell subpopula-
tions including differences in ATP generation (45), com-
partmentalization of ATP responses into discrete do-
mains (eg, in the subplasmamembrane space) that remain
undetectable at the resolutions employed here (21), and
probe saturation returning values under the 20% thresh-
old for inclusion as responsive cells.
Of note, GLP-1 was able to influence ATP/ADP dy-
namics within a matter of minutes, principally by altering
both levels and patterning, and the former effect was con-
firmed using static biochemical assays. The significance of
the reported changes to ATP dynamics remains unknown.
Given that GLP-1 increases intracellular Ca2 load (17),
the pronounced and rapid downward deflections in [ATP/
ADP]cyto may reflect either Ca
2-dependent ATP-con-
suming processes (eg, exocytosis, Ca2 store refilling,
etc.), or alternatively, a mechanism to prevent mitochon-
drial Ca2 toxicity, both of which are rapidly balanced by
augmented metabolism. In terms of the latter mechanism,
the uptake of ATP into the mitochondrial matrix via the
Ca2-activated ATP-Mg/Pi transporter would buffer in-
tramitochondrial [Ca2], preventing mitochondrial per-
meability transition and cell death at the expense of
[ATP/ADP]cyto.
Although mitochondrial Ca2 uptake stimulates
NADH production to drive respiratory chain activity and
ATP synthesis (37), an exaggerated flux of Ca2 across
the inner mitochondrial membrane can constrain ATP
production by reducing the electrochemical gradient that
powers proton pumping and F1/F0 ATP-synthase activity.
We therefore used TMRE to monitor whether GLP-1 was
able to alter m to evoke [ATP/ADP]cyto rises. Whereas
glucose exerted a rapid and large hyperpolarizing influ-
ence upon m, as previously reported (26), this was much
less pronounced in incretin-stimulated islets. The rela-
tively larger increases in ATP detected in response to
GLP-1 per unit decrease in m is consistent with a higher
rate of Ca2 entry and ATP consumption in response to
glucose than incretin (eg, to drive increased secretory
granule dynamics, ion pumping, and protein synthesis).
In line with our previous reports usingMIN6 beta cells
(15), GLP-1 was able to modulate ATP/ADP dynamics
even under conditions of low glucose. Although changes
in [ATP/ADP]cyto would be expected to close hyperpolar-
izing KATP channels, leading to depolarization and Ca
2
influx, GLP-1 was unable to increase cytosolic free Ca2
in beta cells exposed to nonpermissive glucose concentra-
tion. Thus, other glucose-derived signals may be required
to translate GLP-1-induced oscillations in [ATP/ADP]cyto
into Ca2 rises and Ca2-dependent insulin secretion. In-
Figure 5. GLP-1-regulated [ATP/ADP]cyto dynamics are species-
specific. A, Top panel: GLP-1 induces highly synchronized [ATP/ADP]cyto
oscillations in mouse islets (representative traces from three individual
beta cells). Although GLP-1 induces similar ATP rises in human islets
(68), population dynamics are largely stochastic. Bottom panel:
heatmap depicting min-max (0–100%) for each cell in grayscale. B,
Mean percentage significantly correlated cell pairs is lower in GLP-1-
treated human vs mouse islets (**, P  .01 vs mouse; Mann-Whitney
U test) (n  8 recordings from three donors and four animals). C,
Representative connectivity map displaying the location (x-y) of
significantly correlated cell pairs from the GLP-1-responsive beta cell
population. Note the relative paucity and weakness of correlated links
in human vs mouse islets (P  .05) (correlation strength is color-coded;
0 [blue]  lowest, 1 [red]  highest).
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deed, glucose and GLP-1 engage distinct ACs (46), and
summation and/or cell compartmentalization of the ensu-
ing changes to cAMP-Epac dynamics may therefore be
required to fully sensitize KATP to GLP-1-stimulated al-
terations to beta cell metabolism (47, 48). Although the
mechanisms underlying GLP-1 effects at low glucose re-
main unknown, they may implicate a role for mitochon-
drial m that was altered by the incretin even in the pres-
ence of nonpermissive levels of the sugar.
Simultaneous recordings of Perceval and Fura Red re-
vealed that GLP-1 elicited rises in [ATP/ADP]cyto before
those of [Ca2]i, supporting the notion that metabolism
and KATP are required to initiate GLP-1-stimulated Ca
2
influx. It is worthwhile to note that the response time for
Perceval (seconds) is much slower than that for Fura Red
(milliseconds) (23, 49), meaning that the lag between the
onset of [ATP/ADP]cyto and Ca
2 increases was likely
underestimated. Continued effects of GLP-1 upon beta
cell metabolism were dependent upon Ca2 influx
through L-type VDCCs, because the incretin was unable
to stimulate [ATP/ADP]cyto rises in cells pretreated with
EGTA and verapamil. This is unsurprising given our re-
cent findings thatmitochondrial Ca2 uptake through the
mitochondrial Ca2 uniporter is critical for rendering
beta cells glucose competent (24, 26). This effect is most
likely achieved through the Ca2-stimulated up-regula-
tion of mitochondrial dehydrogenase activity, which sup-
plies reducing equivalents to the respiratory chain, lead-
ing to enhanced ATP production (50, 51). Although it
could be argued that the observed effects were due to
blockade of glucose actions, which then reappeared fol-
lowing washout, it should be noted that GLP-1 was un-
able to alter [ATP/ADP]cyto during antagonist applica-
tion, making an effect of the incretin on beta cell
metabolism via a nonextracellular
Ca2-linked pathway unlikely. We
observed that, following washout of
both verapamil and exendin 9-39,
the increases in [ATP/ADP]cyto were
smaller than those observed under
control conditions; this may reflect
residualblockadeofGLP-1R/VDCCor
alternatively slow dissociation ki-
netics due to use of a perfusion
system.
A key observation here (Figure
4B) was that the onset of GLP-1-in-
duced increases in [ATP/ADP]cyto
occurred before detectable changes
in cytosolic free Ca2. What, there-
fore, may be the mechanisms
through which GLP-1 leads to an
apparent direct stimulation of ATP synthesis? A recent
report (52) has suggested that the GLP-1 receptor agonist
geniposidemay stimulate pyruvate carboxylase activity in
beta cells to promote anaplerosis into the citrate cycle and
hence ATP synthesis (53). These observations are in line
with the present findings and provide one possible mech-
anism through which elevated cAMP may enhance ATP
production. Other possibilities include stimulation of glu-
cokinase (54), enhanced protein kinase A–dependent
breakdown of fuel stores such as glycogen or triglycerides
(55) and, conceivably, activation of glycolytic enzymes
including phosphofructokinase (56). Finally we note, in-
triguingly, that intramitochondrial cAMP levels may fluc-
tuate independently of those in the cytosol (57) to regulate
intramitochondrial ATP synthesis, though whether
GLP-1 is able to engage this pathway is unclear given the
apparent impermeability of the mitochondrial inner
membrane to cAMP.
We have recently shown that human islets mount
poorly coordinated Ca2 responses to glucose, but high
levels of correlated activity between beta cells can be
driven by GLP-1 in a process termed “incretin-regulated
connectivity.” By contrast, mouse islets already display
high levels of coordinated activity in response to glucose,
and GLP-1 acts to increase time spent in the active state
while maintaining synchronicity within the beta cell syn-
cytium (17, 58). We therefore sought to clarify whether
these species differences in incretin potentiation of glu-
cose-stimulated insulin secretion were accompanied by
alterations to metabolism. Interestingly, whereas GLP-1-
induced [ATP/ADP]cyto dynamics were highly correlated
across the responsive beta cell subpopulation in mice,
they were more stochastic in human islets. Thus, GLP-1 is
a poor orchestrator of metabolic communications be-
Figure 6. Schematic of GLP-1-modulated beta cell energetics. Glycolytic metabolism of glucose
stimulates insulin secretion through increases in [ATP/ADP]cyto and cAMP, leading to opening of
VDCC and Ca2 influx, the latter reinforcing ATP synthesis. GLP-1 augments glucose-stimulated
insulin secretion by increasing cAMP input, leading to potentiated [ATP/ADP]cyto rises and Ca
2
influx.
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tween human beta cells, and such uncoupling of meta-
bolic and ionic oscillations may contribute to species-
specific regulation of the incretin axis. Although the
mechanisms remain unexplored, they may reflect diver-
gent islet architecture, paracrine/autocrine signaling cir-
cuits, and gap junction function in human vs mouse tissue
(58, 59). We cannot exclude, however, a role for species-
differences in beta cell physiology introduced by islet iso-
lation procedures, cold ischemia time, the relative imma-
turity of mouse compared with human islets, and the
more varied nature of human islet material in terms of
sex, age, and body mass index (see references (60, 61) for
useful discussion).
Finally, although we refer to measurement of [ATP/
ADP]cyto throughout the present study, in the case of Per-
ceval, this requires ADP levels commensurate with probe
affinity (23). Because calculation of free ATP and ADP
cannot readily be inferred from total levels due to nucle-
otide sequestration in organelles and cytoskeleton bind-
ing (41, 62), the actual parameter under measure may
vary. Similarly, our own measurements of total ATP,
while most easily explained through changes in phos-
phorylation potential and ATP/ADP ratio (63), could
conceivably reflect a change in the concentration of ATP
alone. Future studies using probes with a range of affinity
values will therefore be required to accurately quantify
the effects of glucose and incretin on intracellular
[ATP/ADP]cyto.
In summary, we show that GLP-1 is able to influence
beta cell intermediary metabolism through alterations to
the extent and patterning of intracellular ATP/ADP in-
creases. This requires GLP-1R signaling, changes to m
and extracellular Ca2 influx, and displays marked spe-
cies divergence in “metabolic connectivity,” as human
beta cells fail to properly coordinate [ATP/ADP]cyto oscil-
lations. Thus, alterations to beta cell metabolism may
contribute to the diverse and glucose-dependent actions
of incretin, including potentiation of insulin secretion and
prevention of apoptosis.
Materials and Methods
Mouse islet isolation
Animals weremaintained in individually ventilated cages in a
specific pathogen–free facility under a 12-h light-dark cycle with
ad libitum access to water and food. Mice (8–12 weeks old)
were euthanized by cervical dislocation and pancreatic islets
isolated by collagenase digestion, as described (64). Animal pro-
cedures were approved by the Home Office according to the
Animals (Scientific Procedures) Act 1986 of the United King-
dom (PPL 70/7349).
Human islet isolation
Human islets (donor age range, 34–52 years) were isolated at
transplantation facilities in Oxford, Geneva, and Pisa with the
relevant national and local ethical permissions, including con-
sent from next of kin where required. Islets were cultured as
previously described (17). All studies involving human tissue
were approved by the National Research Ethics Committee
London (Fulham) “Signal Transduction in isolated human is-
lets: regulation by glucose and other stimuli” REC No.
07/H0711/114.
Adenoviral delivery of Perceval
Complementary DNA encoding the ATP/ADP sensor Per-
ceval (a kind gift from Professor Gary Yellen) was cloned and
packaged into adenovirus as described (25, 26). Forty-eight-
hour incubation with virus was sufficient to express Perceval
throughout the first few islet cell layers.
Immunohistochemistry
Islets were fixed overnight at 4 C in paraformaldehyde (4%,
wt/vol) before application of guinea pig anti-insulin 1:200 and
mouse anti-glucagon 1:1000 antibodies, and processing as previ-
ously described (17). Uniform linear adjustments were applied to
contrast/brightness to improve image quality for presentation.
ATP/ADP and Ca2 imaging
Perceval-expressing islets were placed in a custom-manufac-
tured 36 C chamber (Digital Pixel) and perifused with a HEPES-
bicarbonate buffer (120 mM NaCl, 4.8 mM KCl, 24 mM
NaHCO3, 0.5 mM Na2HPO4, 5 mM HEPES, 2.5 mM CaCl2,
and 1.2 mM MgCl2) saturated with 95% O2/5% CO2 and ad-
justed to pH 7.4. A solid-state 491-nm laser was passed through
a Nipkow spinning-disk head (Yokogawa CSU-10) coupled
to 	10–	20/0.3–0.5NA objectives (EC Plan-Neofluar, Zeiss).
Emitted signals (510–540 nm) were subsequently captured at a
frame rate of 0.2 Hz using a highly-sensitive 16-bit 512	512-
pixel electron multiplying charge-coupled device (Hamamatsu).
Perceval-expressing cells were manually delineated using a re-
gion of interest and intensity over time traces extracted. Signals
were normalized using the function F/Fmin where F is fluores-
cence at a given time point and Fmin is the minimum recorded
fluorescence.
Multiparametric recordings of [ATP/ADP]cyto and [Ca
2]i
were performed as previously detailed (25, 26). Briefly, Per-
ceval-expressing cells were loaded with Fura-Red and both fluo-
rophore emissions acquired at 0.2 Hz using an Olympus IX-71
microscope equipped with a UPlanFL N 	40/1.3NA objective.
The excitation/emissionwavelengths were (nm): 490/630 (Fura-
Red) and 490/535 (Perceval). GLP-1-induced pH changes were
determined using the ratiometric dye 2
,7
-Bis(2-carboxyethyl)-
5(6)-carboxyfluorescein.
Biochemical detection of ATP
Batches of 10 islets were treated as indicated for 30 minutes
before removal of supernatant and extraction of lysate using
either percholoric acid or distilled boiling H2O followed by
sonication and storage on ice (65, 66). ATP concentration in the
supernatant was immediately assayed using a luciferase-based
detection kit according to the manufacturer’s instructions (ATP
Determination Kit, Life Technologies).
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TMRE imaging
Islets were incubated in 20 nM TMRE for 30 minutes
before imaging as above, but using excitation and emission
wavelengths of 563 nm and 600 nm, respectively. Treatments
were applied as indicated and at the end of each recording,
carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone was
added at 2 M.
Correlation and wavelet analyses
Correlation analyses were performed using the Pearson r
coefficient as previously detailed (P .05) (17, 67). Phase maps
were compiled by converting the normalized intensity of each
cell to a value between 1–100% and assigning this to a color. To
depict the contribution of period to [ATP/ADP]cyto dynamics,
the frequency and time components of the mean Perceval fluo-
rescence trace were extracted using bias-corrected wavelet
analysis.
Statistical analysis
Data distribution was determined using the D’Agostino om-
nibus test. Pairwise comparisons were performed using Mann-
Whitney U test or Student unpaired and paired t tests. Interac-
tions between multiple treatments were assessed using one-way
ANOVA followed by Bonferonni’s post hoc test. A sigmoidal fit
was used to calculate the EC50 of normalized and log-trans-
formed dose-response curves. Analyses were conducted using R
(R-project), Graphpad Prism (Graphpad Software) and IgorPro
(Wavemetrics), and results deemed significant at P  .05.
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